Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 187-

  Kallio, E ^a   Koskinen, P ^a   Buchdunger, E ^b   Lemstrom K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; N [4 METHYL 3 [4 (3 PYRIDINYL) 2 PYRIMIDINYLAMINO]PHENYL]BENZAMIDE;

ANIMAL EXPERIMENT; BRONCHIOLITIS; CONFERENCE PAPER; DRUG EFFECT; ENZYME INHIBITION; GRAFT VERSUS HOST REACTION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; TRACHEA;

ANIMALS; BRONCHIOLITIS OBLITERANS; ENZYME INHIBITORS; POSTOPERATIVE COMPLICATIONS; PYRIDINES; PYRIMIDINES; RATS; RATS, INBRED STRAINS; RATS, INBRED WF; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; TRACHEA; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0344457219     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01496-1     Document Type: Conference Paper

References (4)

1. Hosenpud J.D., Bennett L.E., Berkeley M., et al. J Heart Lung Transplant. 16:1997;691.
2. Hertz M.I., Henke C.A., Nakhleh R.E., et al. Proc Natl Acad Sci. 89:1992;10385.
3. Buchdunger E., Zimmermann J., Mett H., et al. Proc Natl Acad Sci. 92:1995;2558.
4. Koskinen P.K., Kallio E.A., Krebs R., et al. Am J Resp Crit Care Med. 155:1997;303.